Novavax raises doubts about its ability to remain in business
COVID-19 vaccine maker Novavax Inc (NVAX.O) on Tuesday raised doubts about its ability to remain in business and announced plans to slash spending as it works to prepare for a fall vaccination campaign. The company said there is significant uncertainty around its 2023 revenue, funding from the…
#novavaxinc #refinitiv #novavax #johnjacobs #jacobs #fda #pfenbiontech #michaelerman #carolinehumer #billberkrot